HELX holdings — Franklin Genomic Advancements ETF
Franklin Genomic Advancements ETF (HELX) held 63 positions with net assets of $27.9M as of June 30, 2026, according to its Form N-PORT report to the SEC. Its top 10 holdings make up 47.1% of the fund, led by GH, NTRA, KRYS.
HELX top holdings
- GH GUARDANT HEALTH INC — 9.09% ($2.54M)
- NTRA NATERA INC — 7.46% ($2.08M)
- KRYS KRYSTAL BIOTECH INC — 6.33% ($1.77M)
- LGND LIGAND PHARMACEUTICALS INC — 4.62% ($1.29M)
- ADPT ADAPTIVE BIOTECHNOLOGIES CORP — 3.99% ($1.11M)
- UTHR UNITED THERAPEUTICS CORP — 3.51% ($980K)
- BBIO BRIDGEBIO PHARMA INC — 3.50% ($978K)
- LLY ELI LILLY & COMPANY — 2.95% ($825K)
- TWST TWIST BIOSCIENCE CORP — 2.85% ($796K)
- VRTX VERTEX PHARMACEUTICALS INC — 2.75% ($767K)
- AZN ASTRAZENECA PLC — 2.70% ($754K)
- TVTX TRAVERE THERAPEUTICS INC — 2.59% ($724K)
- INSM INSMED INC — 2.44% ($681K)
- 207940 SAMSUNG BIOLOGICS CO LTD — 2.26% ($630K)
- CTVA CORTEVA INC — 2.25% ($630K)
- MEDP MEDPACE HOLDINGS INC — 2.15% ($600K)
- ALNY ALNYLAM PHARMACEUTICALS INC — 1.96% ($547K)
- TEM TEMPUS AI INC — 1.95% ($544K)
- IONS IONIS PHARMACEUTICALS INC — 1.91% ($534K)
- NBIX NEUROCRINE BIOSCIENCES INC — 1.84% ($515K)
- REGN REGENERON PHARMACEUTICALS INC — 1.80% ($502K)
- VCYT VERACYTE INC — 1.64% ($459K)
- ARGX ARGENX SE — 1.64% ($458K)
- PTCT PTC THERAPEUTICS INC — 1.46% ($409K)
- BNTX BIONTECH SE — 1.38% ($387K)
What are HELX's top 10 holdings?
GH (9.1%), NTRA (7.5%), KRYS (6.3%), LGND (4.6%), ADPT (4.0%), UTHR (3.5%), BBIO (3.5%), LLY (3.0%), TWST (2.8%), VRTX (2.7%).
How many stocks are in HELX?
Franklin Genomic Advancements ETF reported 63 holdings as of June 30, 2026.